Titelia

Fund shareholders of Larimar Therapeutics Inc

ISIN US5171251003 · United States · LEI 529900NCBZHTTJV6HX73

Fund shareholders
125
Of which ETFs
23 102 other funds
Value held
42.8M $
Share of capital
9.1 % of 103.9M shares on Aug 2, 2026
FundSharesValueWeight in fundShare of capital
ProShares Russell 2000 High Income ETF ProShares Trust 2,10311.2K $0.01 %0.00 %as of Feb 28, 2026
Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS 1,88610K $0.00 %0.00 %as of Feb 28, 2026
EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust 1,8588.4K $0.00 %0.00 %as of Mar 31, 2026
SmallCap Value Fund II Principal Funds, Inc 1,8207.4K $0.00 %0.00 %as of Apr 30, 2026
Avantis U.S. Small Cap Equity Fund American Century ETF Trust 1,5548.3K $0.01 %0.00 %as of Feb 28, 2026
Total Stock Market Index Trust John Hancock Variable Insurance Trust 1,5286.9K $0.00 %0.00 %as of Mar 31, 2026
Penn Series Small Cap Index Fund Penn Series Funds Inc 1,5006.8K $0.01 %0.00 %as of Mar 31, 2026
Avantis U.S. Equity ETF American Century ETF Trust 1,4007.4K $0.00 %0.00 %as of Feb 28, 2026
Dimensional U.S. Equity Market ETF Dimensional ETF Trust 1,1564.7K $0.00 %as of Apr 30, 2026
State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC 1,1465.2K $0.00 %0.00 %as of Mar 31, 2026
Nuveen Life Stock Index Fund TIAA-CREF Life Funds 9694.4K $0.00 %0.00 %as of Mar 31, 2026
ULTRA SMALL CAP PROFUND ProFunds 5332.2K $0.00 %0.00 %as of Apr 30, 2026
Small Cap Core Fund Northern Funds 3751.7K $0.00 %0.00 %as of Mar 31, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 2901.2K $0.00 %0.00 %as of Apr 30, 2026
Russell 2000 2x Strategy Fund Rydex Dynamic Funds 216972 $0.00 %0.00 %as of Mar 31, 2026
PROFUND VP ULTRA SMALL CAP ProFunds 158711 $0.00 %0.00 %as of Mar 31, 2026
PROFUND VP SMALL CAP ProFunds 119535.5 $0.00 %0.00 %as of Mar 31, 2026
Russell 2000 Fund Rydex Series Funds 99445.5 $0.00 %0.00 %as of Mar 31, 2026
SMALL-CAP PROFUND ProFunds 86349.2 $0.00 %0.00 %as of Apr 30, 2026
Russell 2000 1.5x Strategy Fund Rydex Series Funds 59265.5 $0.00 %0.00 %as of Mar 31, 2026
ProShares Hedge Replication ETF ProShares Trust 50265.5 $0.00 %0.00 %as of Feb 28, 2026
Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I 48216 $0.01 %0.00 %as of Mar 31, 2026
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds 33148.5 $0.00 %as of Mar 31, 2026
ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust 1474.3 $0.01 %0.00 %as of Feb 28, 2026
Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust 1149.5 $0.00 %0.00 %as of Mar 31, 2026

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Driehaus Micro Cap Growth Fund Driehaus Mutual Funds 0.34 %as of Mar 31, 2026
iShares Neuroscience and Healthcare ETF iShares Trust 0.18 %as of Apr 30, 2026
GMO U.S. Small Cap Value Fund GMO TRUST 0.16 %as of Feb 28, 2026
Ultra-Small Company Market Fund Bridgeway Funds, Inc. 0.13 %as of Mar 31, 2026
Federated Hermes MDT Small Cap Core ETF Federated Hermes ETF Trust 0.12 %as of Feb 28, 2026
Adara Smaller Companies Fund RBB Fund, Inc. 0.09 %as of Feb 28, 2026
Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund Goldman Sachs Variable Insurance Trust 0.09 %as of Mar 31, 2026
Small Cap Value Fund VALIC Co I 0.09 %as of Feb 28, 2026
NVIT GS Small Cap Equity Insights Fund Nationwide Variable Insurance Trust 0.08 %as of Mar 31, 2026
JPMorgan Small Cap Value Fund JPMorgan Trust II 0.08 %as of Mar 31, 2026

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q2125+219,470,650+21.7 %
2026Q1104+87,784,385+9.4 %
2025Q496+67,116,798+23.6 %
2025Q390-85,759,369-2.0 %
2025Q298-95,875,142-14.4 %
2025Q1107-76,865,916-12.5 %
2024Q4114+17,848,345+7.8 %
2024Q3113+107,279,308+27.2 %
2024Q2103+155,724,027+58.4 %
2024Q188+33,613,247+8.8 %
2023Q4853,320,986

Institutional managers

157 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
DEERFIELD MANAGEMENT COMPANY, L.P.35,606,974160.2M $as of Mar 31, 2026
Blue Owl Capital Holdings LP7,120,00732M $as of Mar 31, 2026
BlackRock, Inc.3,752,20016.9M $as of Mar 31, 2026
MILLENNIUM MANAGEMENT LLC3,625,27816.3M $as of Mar 31, 2026
AIGH Capital Management LLC3,000,00013.5M $as of Mar 31, 2026
Driehaus Capital Management LLC2,934,39913.2M $as of Mar 31, 2026
DAFNA Capital Management LLC2,029,1649.1M $as of Mar 31, 2026
GOLDMAN SACHS GROUP INC1,561,5857M $as of Mar 31, 2026
Deep Track Capital, LP1,500,0006.8M $as of Mar 31, 2026
RTW INVESTMENTS, LP1,500,0006.8M $as of Mar 31, 2026
Woodline Partners LP1,400,8506.3M $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC1,108,7615M $as of Mar 31, 2026
Soleus Capital Management, L.P.1,066,9604.8M $as of Mar 31, 2026
Point72 Asset Management, L.P.1,047,3854.7M $as of Mar 31, 2026
MARSHALL WACE, LLP933,4644.2M $as of Mar 31, 2026
STATE STREET CORP911,3264.1M $as of Mar 31, 2026
Gem Investment Advisors, LLC854,2303.8M $as of Mar 31, 2026
Qube Research & Technologies Ltd847,6443.8M $as of Mar 31, 2026
AQR CAPITAL MANAGEMENT LLC817,5173.7M $as of Mar 31, 2026
DIMENSIONAL FUND ADVISORS LP798,4623.6M $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC739,9423.3M $as of Mar 31, 2026
Nuveen, LLC674,9153M $as of Mar 31, 2026
Caption Management, LLC635,0242.9M $as of Mar 31, 2026
Alyeska Investment Group, L.P.617,2112.8M $as of Mar 31, 2026
D. E. Shaw & Co., Inc.575,6242.6M $as of Mar 31, 2026

Declared shareholders of Larimar Therapeutics Inc

There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
Blue Owl Capital Holdings LP 9.99 %10,739,492as of Mar 31, 2026 · SCHEDULE 13G
Millennium Management LLC and 2 others3.50 %3,625,278as of Mar 31, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Fund shareholders of Larimar Therapeutics Inc". https://titelia.com/en/stocks/larimar-therapeutics-inc-US5171251003